Remission of severe aplastic anemia associated with hepatitis B virus infection after viral clearance: potential role of lamivudine

Dig Dis Sci. 2002 Aug;47(8):1782-5. doi: 10.1023/a:1016444611997.

Abstract

Although viral hepatitis infection is known to be associated with aplastic anemia, a causal link between viral hepatitis and aplastic anemia has not been convincingly demonstrated. A case of hepatitis B-associated severe aplastic anemia is described which only partially responded to conventional immunosuppressive treatment but went into complete clinical remission after clearance of the hepatitis B virus. Disappearance of the hepatitis B virus occurred during lamivudine treatment and coincided with immune activation secondary to discontinuation of immunosuppressive therapy. This case was somewhat atypical in that a history of acute hepatitis preceding the aplastic anemia was absent. The observation made in this case report supports a cause-effect relationship between hepatitis B virus infection and aplastic anemia.

Publication types

  • Case Reports

MeSH terms

  • Adult
  • Anemia, Aplastic / etiology*
  • Antiviral Agents / therapeutic use*
  • Hepatitis B / complications*
  • Hepatitis B / drug therapy*
  • Hepatitis B / virology
  • Humans
  • Lamivudine / therapeutic use*
  • Male
  • Remission, Spontaneous

Substances

  • Antiviral Agents
  • Lamivudine